90ug levonorgestrel / 20 ug ethinyl estradiol + Oral Contraceptives containing 20 ug of ethinyl estradiol
Pre-clinicalCompleted 0 watching 0 views this week💤 Quiet
22
Development Stage
1
Pre-clinical2
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Venous Thrombosis
Conditions
Venous Thrombosis, Pulmonary Embolism, Sinus Thrombosis, Intracranial
Trial Timeline
Jul 1, 2007 → Apr 1, 2012
NCT ID
NCT01297348About 90ug levonorgestrel / 20 ug ethinyl estradiol + Oral Contraceptives containing 20 ug of ethinyl estradiol
90ug levonorgestrel / 20 ug ethinyl estradiol + Oral Contraceptives containing 20 ug of ethinyl estradiol is a pre-clinical stage product being developed by Pfizer for Venous Thrombosis. The current trial status is completed. This product is registered under clinical trial identifier NCT01297348. Target conditions include Venous Thrombosis, Pulmonary Embolism, Sinus Thrombosis, Intracranial.
Hype Score Breakdown
Clinical
5
Activity
2
Company
9
Novelty
2
Community
1
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT01297348 | Pre-clinical | Completed |
Competing Products
20 competing products in Venous Thrombosis